Skip to Main Content

McGraw-Hill Education responds to the changing needs of pharmacy education with the release or Pharmacotherapy Principles and Practice, available for the first time with AccessPharmacy®


Enhanced learning content provides critical knowledge and skill for a growing profession in high demand

NEW YORK – June 16, 2015 – McGraw-Hill Education, the learning science company, announced that the classic text Pharmacotherapy: Principles and Practice, Third Edition, is now available online for the first time via AccessPharmacy®, McGraw-Hill Education’s comprehensive, content-rich online resource for pharmacy students and instructors and practicing pharmacists.


Pharmacotherapy Principles & Practice is widely acknowledged as one of the premier texts in the field. It uses a solid evidence-based approach to teach how to design, implement, monitor, and evaluate medication therapy. This trusted text provides everything needed to gain an in-depth understanding of the principles essential to optimal pharmacotherapy of disease. It consists of more than 100 disease-based chapters that review etiology, epidemiology, pathophysiology, and clinical presentation, followed by therapeutic recommendations for drug selection, dosing, and patient monitoring. In order to be as clinically relevant as possible, the disease states and treatments discussed focus on disorders most often seen in clinical practice.


In addition to providing an authoritative content library, AccessPharmacy offers powerful tools and features that deliver indispensable clinical and educational support. A key component is Custom Curriculum, a powerful workflow tool that enables pharmacy faculty to customize content as well as manage students’ and residents’ training from one convenient site.


“The decision to add Pharmacotherapy Principles and Practice to our suite of medical products was in direct response to feedback from the pharmacy education community for online access to this important resource. It means that instructors are now able to seamlessly integrate this cornerstone text directly into their curriculum,” said Scott Grillo, vice president of McGraw-Hill Education’s Professional group.


AccessPharmacy licensees have the option to add Pharmacotherapy Principles and Practice to their subscription for a supplemental fee. Also included is Pharmacotherapy Principles and Practice Study Guide, which features more than 100 patient cases that correspond to chapters in the core text. As an addendum to AccessPharmacy, these essential books join the fully searchable and complete content of more than 30 leading pharmacy textbooks including Pharmacotherapy: A Pathophysiologic Approach, Applied Biopharmaceutics and Pharmacokinetics, Basic & Clinical Pharmacology, Casarett & Doull’s Essentials of Toxicology, and Goodman & Gilman’s The Pharmacological Basis of Therapeutics.


Both institutional and individual subscriptions are available and the product platform offers responsive design for mobile for great viewing on any device.


About AccessPharmacy®
AccessPharmacy® from McGraw-Hill Education is a comprehensive, content-rich online pharmacy resource that allows users to explore leading pharmacy references, search curriculum topics, and research drugs and supplements—all in one place. Updated regularly, it gives pharmacy students instant access to videos, self-assessment, and leading pharmacy textbooks that will establish an important foundation for learning and enables pharmacy instructors to create assignments, and track and report their students’ progress through a curriculum workflow tool. For more information visit http://accesspharmacy.com. 


About McGraw-Hill Education
McGraw-Hill Education is a learning science company that delivers personalized learning experiences to help students, parents, educators, and professionals drive results. McGraw-Hill Education has offices across North America, India, China, Europe, the Middle East and South America, and makes its learning solutions available in nearly 60 languages. Visit us at mheducation.com or find us on Facebook or Twitter.